-
公开(公告)号：US20230193207A1
公开(公告)日：2023-06-22
申请号：US18046787
申请日：2022-10-14
Applicant: Factor Bioscience Inc.
Inventor： Matthew Angel , Christopher Rohde , Jasmine Harris
IPC: C12N5/0775 , A61P35/00 , A61P11/00
CPC classification number: C12N5/0668 , A61P35/00 , A61P11/00 , C12N2506/45 , C12N2501/60
Abstract: Cell-based therapies based on mesenchymal stem cells (MSCs) are described.
-
公开(公告)号：US11492600B2
公开(公告)日：2022-11-08
申请号：US16562497
申请日：2019-09-06
Applicant: Factor Bioscience Inc.
Inventor： Matthew Angel , Christopher Rohde
Abstract: The present invention relates in part to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these methods. Methods for reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed.
-
公开(公告)号：US11466293B2
公开(公告)日：2022-10-11
申请号：US16567059
申请日：2019-09-11
Applicant: Factor Bioscience Inc.
Inventor： Matthew Angel , Christopher Rohde
IPC: C12N15/87 , C08K5/5399 , C12N5/074 , H01L31/048 , C12P21/00 , C12N9/16 , C12N5/0789 , C12N5/077 , C12N15/90 , C12N9/22 , A61K35/28 , C08G77/08 , A61K35/12
Abstract: The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.
-
公开(公告)号：US11339410B2
公开(公告)日：2022-05-24
申请号：US16654726
申请日：2019-10-16
Applicant: Factor Bioscience Inc.
Inventor： Matthew Angel , Christopher Rohde
IPC: C07H21/04 , C12N15/63 , C12N15/90 , A61K31/7115 , C12N9/22 , C07K14/195 , C12N15/10 , A61K35/14 , A61K38/46 , A61K48/00 , C12N15/86 , G01N33/50 , A61K31/70 , A61K35/12
Abstract: The present invention relates in part to nucleic acids encoding proteins, therapeutics comprising nucleic acids encoding proteins, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods and products for altering the DNA sequence of a cell are described, as are methods and products for inducing cells to express proteins using synthetic RNA molecules. Therapeutics comprising nucleic acids encoding gene-editing proteins are also described.
-
公开(公告)号：US10982229B2
公开(公告)日：2021-04-20
申请号：US16869232
申请日：2020-05-07
Applicant: Factor Bioscience Inc.
Inventor： Matthew Angel , Christopher Rohde
IPC: C12N15/85 , C12N15/87 , C08K5/5399 , C12N5/074 , H01L31/048 , C12P21/00 , C12N9/16 , C12N5/0789 , C12N5/077 , C12N15/90 , C12N9/22 , A61K35/28 , C08G77/08 , A61K35/12
Abstract: The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.
-
Patent Agency Ranking
公开(公告)号：US20210009955A1
公开(公告)日：2021-01-14
申请号：US16913315
申请日：2020-06-26
Applicant: Factor Bioscience Inc.
Inventor： Matthew ANGEL , Christopher ROHDE
IPC: C12N5/0789 , C08K5/5399 , C12N5/074 , H01L31/048 , C12N15/87 , C12P21/00 , C12N9/16 , C12N5/077 , C12N15/90 , C12N9/22 , A61K35/28
Abstract: The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.
-
公开(公告)号：US20200040363A1
公开(公告)日：2020-02-06
申请号：US16655760
申请日：2019-10-17
Applicant: Factor Bioscience Inc.
Inventor： Matthew ANGEL , Christopher ROHDE
IPC: C12N15/90 , C12N15/86 , A61K35/14 , C12N9/22 , A61K38/46 , G01N33/50 , C12N15/10 , A61K48/00 , A61K31/7115 , C07K14/195
Abstract: The present invention relates in part to nucleic acids encoding proteins, therapeutics comprising nucleic acids encoding proteins, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods and products for altering the DNA sequence of a cell are described, as are methods and products for inducing cells to express proteins using synthetic RNA molecules. Therapeutics comprising nucleic acids encoding gene-editing proteins are also described.
-
公开(公告)号：US20200032298A1
公开(公告)日：2020-01-30
申请号：US16655766
申请日：2019-10-17
Applicant: Factor Bioscience Inc.
Inventor： Matthew ANGEL , Christopher ROHDE
IPC: C12N15/90 , C12N15/86 , A61K35/14 , C12N9/22 , A61K38/46 , G01N33/50 , C12N15/10 , A61K48/00 , A61K31/7115 , C07K14/195
Abstract: The present invention relates in part to nucleic acids encoding proteins, therapeutics comprising nucleic acids encoding proteins, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods and products for altering the DNA sequence of a cell are described, as are methods and products for inducing cells to express proteins using synthetic RNA molecules. Therapeutics comprising nucleic acids encoding gene-editing proteins are also described.
-
公开(公告)号：US20190000996A1
公开(公告)日：2019-01-03
申请号：US16030674
申请日：2018-07-09
Applicant: Factor Bioscience Inc.
Inventor： Matthew ANGEL , Christopher ROHDE
IPC: A61K48/00 , A61P3/10 , A61P35/00 , A61P29/00 , A61P9/00 , A61P3/00 , A61P11/00 , A61P1/16 , A61K31/7115 , C12N9/22 , C07K14/00 , A61P3/06
CPC classification number: A61K48/005 , A61K9/0019 , A61K31/7115 , A61K48/0058 , A61K48/0066 , A61P1/16 , A61P3/00 , A61P3/06 , A61P3/10 , A61P9/00 , A61P11/00 , A61P29/00 , A61P35/00 , C07K14/001 , C07K14/003 , C12N9/22 , C12N2310/20 , C12Y301/21
Abstract: The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, therapeutics, and cosmetics produced using these methods, kits, and devices.
-
公开(公告)号：US20190000995A1
公开(公告)日：2019-01-03
申请号：US16030670
申请日：2018-07-09
Applicant: Factor Bioscience Inc.
Inventor： Matthew ANGEL , Christopher ROHDE
IPC: A61K48/00 , A61P3/10 , A61P35/00 , A61P29/00 , A61P9/00 , A61P3/00 , A61P11/00 , A61P1/16 , A61K31/7115 , C12N9/22 , C07K14/00 , A61P3/06
CPC classification number: A61K48/005 , A61K9/0019 , A61K31/7115 , A61K48/0058 , A61K48/0066 , A61P1/16 , A61P3/00 , A61P3/06 , A61P3/10 , A61P9/00 , A61P11/00 , A61P29/00 , A61P35/00 , C07K14/001 , C07K14/003 , C12N9/22 , C12N2310/20 , C12Y301/21
Abstract: The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods for delivering nucleic acids to cells, tissues, organs, and patients, methods for inducing cells to express proteins using nucleic acids, methods, kits and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, therapeutics, and cosmetics produced using these methods, kits, and devices.
-
-
-
-
-
-
-
-
-
Search Results
126
records
(took 0.041 seconds)
